Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Change in Accured Expenses: 2009-2025

Historic Change in Accured Expenses for Rockwell Medical (RMTI) over the last 17 years, with Sep 2025 value amounting to -$139,000.

  • Rockwell Medical's Change in Accured Expenses fell 140.06% to -$139,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.6 million, marking a year-over-year decrease of 2652.13%. This contributed to the annual value of -$1.0 million for FY2024, which is 175.00% down from last year.
  • Latest data reveals that Rockwell Medical reported Change in Accured Expenses of -$139,000 as of Q3 2025, which was up 72.37% from -$503,000 recorded in Q2 2025.
  • Over the past 5 years, Rockwell Medical's Change in Accured Expenses peaked at $2.9 million during Q3 2023, and registered a low of -$3.3 million during Q1 2023.
  • Over the past 3 years, Rockwell Medical's median Change in Accured Expenses value was -$283,000 (recorded in 2024), while the average stood at -$337,636.
  • As far as peak fluctuations go, Rockwell Medical's Change in Accured Expenses surged by 600.00% in 2021, and later slumped by 414.84% in 2023.
  • Quarterly analysis of 5 years shows Rockwell Medical's Change in Accured Expenses stood at $777,000 in 2021, then skyrocketed by 128.83% to $1.8 million in 2022, then plummeted by 63.05% to $657,000 in 2023, then plummeted by 143.07% to -$283,000 in 2024, then plummeted by 140.06% to -$139,000 in 2025.
  • Its last three reported values are -$139,000 in Q3 2025, -$503,000 for Q2 2025, and -$1.7 million during Q1 2025.